Back to Search
Start Over
Small RNA-regulated expression of efflux pump affects tigecycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae.
- Source :
-
Microbiological research [Microbiol Res] 2024 Oct; Vol. 287, pp. 127825. Date of Electronic Publication: 2024 Jul 20. - Publication Year :
- 2024
-
Abstract
- Tigecycline and the newly Food and Drug Administration-approved tetracyclines, including eravacycline and omadacycline, are regarded as last-resort treatments for multidrug-resistant Enterobacterales. However, tigecycline resistance in Klebsiella pneumoniae has increased, especially the underlying mechanism of heteroresistance is unclear. This study aimed to elucidate the mechanisms underlying tigecycline resistance and heteroresistance in clinical K. pneumoniae isolates. A total of 153 clinical K. pneumoniae isolates were collected, and identified 15 tigecycline-resistant and three tigecycline-heteroresistant isolates using broth microdilution and population analysis profile methods, respectively. Total RNAs from K. pneumoniae ATCC13883 and the laboratory-induced tigecycline-resistant strain were extracted and sequenced on an Illumina platform. Differentially expressed genes and regulatory small RNAs (sRNAs) were analyzed and validated in clinical isolates of K. pneumoniae using quantitative real-time PCR. RNA sequencing results showed that mdtABC efflux pump genes were significantly upregulated in the tigecycline-resistant strains. Overexpression of mdtABC was observed in a clinical K. pneumoniae isolate, which increased tigecycline minimum inhibitory concentrations (MICs) and was involved in tigecycline heteroresistance. Sequencing analysis of sRNA demonstrated that candidate sRNA-120 directly interacted with the mdtABC operon and was downregulated in tigecycline-resistant strains. We generated an sRNA-120 deletion mutation strain and a complemented strain of K. pneumoniae. The sRNA-120 deletion strain displayed increased mRNA levels of mdtA, mdtB, and mdtC and an increase in MICs of tigecycline. The complemented strain of sRNA-120 restored the mRNA levels of these genes and the susceptibility to tigecycline. RNA antisense purification and parallel reaction monitoring mass spectrometry were performed to verify the interactions between sRNA-120 and mdtABC. Collectively, our study highlights that the post-transcriptional repression of mdtABC through sRNA-120 may provide an additional layer of efflux pump gene expression control, which is important for resistance and heteroresistance in clinical K. pneumoniae isolates.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier GmbH. All rights reserved.)
- Subjects :
- Humans
Membrane Transport Proteins genetics
Membrane Transport Proteins metabolism
Drug Resistance, Bacterial genetics
RNA, Bacterial genetics
Drug Resistance, Multiple, Bacterial genetics
Minocycline pharmacology
Minocycline analogs & derivatives
Klebsiella pneumoniae genetics
Klebsiella pneumoniae drug effects
Klebsiella pneumoniae metabolism
Tigecycline pharmacology
Anti-Bacterial Agents pharmacology
Gene Expression Regulation, Bacterial
Microbial Sensitivity Tests
Klebsiella Infections microbiology
Bacterial Proteins genetics
Bacterial Proteins metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1618-0623
- Volume :
- 287
- Database :
- MEDLINE
- Journal :
- Microbiological research
- Publication Type :
- Academic Journal
- Accession number :
- 39047663
- Full Text :
- https://doi.org/10.1016/j.micres.2024.127825